| Literature DB >> 33296111 |
Yang Heng1, Marissa L Dubbelaar1, Suely K N Marie2, Erik W G M Boddeke1,3, Bart J L Eggen1.
Abstract
Microglia are specialized macrophages of the central nervous system (CNS) and first to react to pathogens or injury. Over the last decade, transcriptional profiling of microglia significantly contributed to our understanding of their functions. In the case of human CNS samples, either potential CNS pathology in the case of surgery samples, or a postmortem delay (PMD) due to the time needed for tissue access and collection, are potential factors that affect gene expression profiles. To determine the effect of PMD on the microglia transcriptome, we first analyzed mouse microglia, where genotype, antemortem conditions and PMD can be controlled. Microglia were isolated from mice after different PMDs (0, 4, 6, 12, and 24 hr) using fluorescence-activated cell sorting (FACS). The number of viable microglia significantly decreased with increasing PMD, but even after a 12 hr PMD, high-quality RNA could be obtained. PMD had very limited effect on mouse microglia gene expression, only 50 genes were differentially expressed between different PMDs. These genes were related to mitochondrial, ribosomal, and protein binding functions. In human microglia transcriptomes we previously generated, 31 of the 50 PMD-associated mouse genes had human homologs, and their relative expression was also affected by PMD. This study provides a set of genes that shows relative expression changes in relation to PMD, both in mouse and human microglia. Although the gene expression changes detected are subtle, these genes need to be accounted for when analyzing microglia transcriptomes generated from samples with variable PMDs.Entities:
Keywords: gene expression profiling; human; microglia; mouse; postmortem delay
Mesh:
Year: 2020 PMID: 33296111 PMCID: PMC7898322 DOI: 10.1002/glia.23948
Source DB: PubMed Journal: Glia ISSN: 0894-1491 Impact factor: 7.452
FIGURE 1The effects of postmortem delay (PMD) on viable fluorescence‐activated cell sorting (FACS)‐sorted mouse microglia numbers and RNA quality. (a) FACS plots depicting the sorting strategy of DAPIneg Ly6Cneg CD11bhigh CD45int microglia and the PMD induced decrease in the percentage of DAPIneg microglia in gate R5. (b) Dot plot depicting the number of DAPIneg microglia sorted from entire mouse brains at different PMD times (n = 4 mice per PMD). (c) Dot plot depicting RIN values of RNA extracted from sorted DAPIneg Ly6Cneg CD11bhigh CD45int microglia at different PMD times (n = 4 mice per PMD). A one‐way ANOVA followed by a Bonferroni correction for multiple comparisons was performed to assess significance. **, p < .01; ***, p < .001
FIGURE 2The effect of postmortem delay (PMD) on the mouse microglia transcriptome. (a) PCA analysis of microglia samples with different PMD. Each dot represents a mouse (n = 4 per PMD interval). (b) Heatmap depicting row z‐scores of 50 PMD‐related genes in mouse microglia identified by pairwise comparisons with a cutoff q‐value < .1. Unsupervised hierarchical clustering resulted in three gene clusters
FIGURE 3The effects of postmortem delay (PMD) on the human microglia transcriptome. (a) Line and ribbon graphs depict expression pattern of mouse genes with a human homologue, divided into three gene clusters that were previously identified in mouse microglia (left). The y‐axis indicates expression values, and postmortem time is depicted on the x‐axis. The line depicts the mean expression values of the genes in their respective cluster, the ribbon illustrates the highest and lowest gene expression values of the given PMD. A heatmap of 31 human homologs of PMD‐related genes identified in mouse (right). Human samples clustered into two groups based on the relative gene expression of PMD‐related homologs. (b,c) Bar plots depicting the median gene expression of PMD‐related genes excluding MT‐CYTB and MT‐ND1 (b) and mean expression of MT‐CYTB and MT‐ND1 (c) for each individual human sample. The PMD for each human sample is indicated. An unpaired t‐test was performed to assess significance. ***, p < .001; ****, p < .0001. (d) Dot plot depicting the PMD time of the samples in Cluster 1 and 2. An unpaired t‐test was used to determine the significance *, p < .05. (e, f) Linear regression analysis for median counts of PMD‐related genes excluding MT‐CYTB and MT‐ND1 (e) and mean counts of MT‐CYTB and MT‐ND1 (f) to PMD time. Results show linear regression lines with 95% confidence limits and Pearson r values with p values indicating degree of significance. **, p < .01